Streetbeat News

Price Targets

AKR

Truist Securities analyst Ki Bin Kim has reiterated a 'Buy' rating on Acadia Realty Trust (NYSE:AKR) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:47 pm

ENVX

Cantor Fitzgerald analyst Derek Soderberg has reiterated an Overweight rating on Enovix (NASDAQ:ENVX), maintaining a $25 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:45 pm

EYPT

Cantor Fitzgerald analyst Jennifer Kim has reiterated an Overweight rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) and maintained a price target of $31.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:43 pm

ARQT

Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Arcutis Biotherapeutics (NASDAQ:ARQT) and maintained a $50 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:43 pm

RZLT

Cantor Fitzgerald analyst Pete Stavropoulos has maintained an Overweight rating on Rezolute (NASDAQ:RZLT) but lowered the price target from $7 to $5.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:41 pm

PRTA

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Prothena Corp (NASDAQ:PRTA) and maintained a price target of $129.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:40 pm

RETA

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Reata Pharmaceuticals (NASDAQ:RETA) and maintained a price target of $110.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:39 pm

CYBN

Cantor Fitzgerald analyst Charles Duncan has reiterated an Overweight rating on Cybin (AMEX:CYBN) and maintained a $3 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:37 pm

XPOF

Roth MKM analyst George Kelly maintains a Buy rating on Xponential Fitness (NYSE:XPOF) but lowers the price target from $40 to $32.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:36 pm

AREC

Roth MKM analyst Mike Niehuser has reiterated a 'Buy' rating on American Res (NASDAQ:AREC) and maintained a $5 price target.

Portfolio Pulse from richadhand@benzinga.com

June 28, 2023 | 2:33 pm